Ann Thorac Surg 2009;88:122-123. doi:10.1016/j.athoracsur.2009.04.028
© 2009 The Society of Thoracic Surgeons
Original Articles: Adult Cardiac
Invited Commentary
Richard Lee, MD, MBA
Division of Cardiothoracic Surgery, Northwestern University, 201 East Huron, Galter 11-140, Chicago, IL 60611
(Email: ricklee@nmh.org).
| The first 20% of the full text of this article appears below. |
Dobutamine is one of the most commonly used inotropic agents after cardiac surgery, and in some countries it is chosen for 65% of patients needing pharmacologic support [1]. Unfortunately, despite the agent's proven efficacy in contractility, up to one third of patients can not tolerate a full dose of the agent, most commonly due to . . . [Full Text of this Article]
Related Article
-
Cardiac Vagal Stimulation Eliminates Detrimental Tachycardia Effects of Dobutamine Used for Inotropic Support
- Youhua Zhang and Todor N. Mazgalev
Ann. Thorac. Surg. 2009 88: 117-122.
[Abstract]
[Full Text]
[PDF]
Copyright © 2009 by The Society of Thoracic Surgeons.